Publications of Guenter Karl Stalla

Kopczak, A.; Stalla, G. K.; Uhr, M.; Lucae, S.; Hennings, J.; Ising, M.; Holsboer, F.; Kloiber, S.: IGF-I in major depression and antidepressant treatment response. EUROPEAN NEUROPSYCHOPHARMACOLOGY 25 (6), pp. 864 - 872 (2015)

Leistner, S. M.; Klotsche, J.; Dimopoulou, C.; Athanasoulia, A. P.; Roemmler-Zehrer, J.; Pieper, L.; Schopohl, J.; Wittchen, H.-U.; Stalla, G. K.; Fulda, S. et al.; Sievers, C.: Reduced sleep quality and depression associate with decreased quality of life in patients with pituitary adenomas. EUROPEAN JOURNAL OF ENDOCRINOLOGY 172 (6), pp. 733 - 743 (2015)

Petersenn, S.; Beckers, A.; Ferone, D.; van der Lely, A.; Bollerslev, J.; Boscaro, M.; Brue, T.; Bruzzi, P.; Casanueva, F. F.; Chanson, P. et al.; Colao, A.; Reincke, M.; Stalla, G. K.; Tsagarakis, S.: Outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence. EUROPEAN JOURNAL OF ENDOCRINOLOGY 172 (6), pp. R227 - R239 (2015)

Yaron, M.; Renner, U.; Gilad, S.; Stalla, G. K.; Stern, N.; Greenman, Y.: KISS1 receptor is preferentially expressed in clinically non-functioning pituitary tumors. PITUITARY 18 (3), pp. 306 - 311 (2015)

Kao, C.-Y.; Stalla, G.; Stalla, J.; Wotjak, C. T.; Anderzhanova, E.: Norepinephrine and corticosterone in the medial prefrontal cortex and hippocampus predict PTSD-like symptoms in mice. EUROPEAN JOURNAL OF NEUROSCIENCE 41 (9), pp. 1139 - 1148 (2015)

Auer, M. K.; Sack, M.; Lenz, J. N.; Jakovcevski, M.; Biedermann, S. V.; Falfan-Melgoza, C.; Deussing, J. M.; Steinle, J.; Bielohuby, M.; Bidlingmaier, M. et al.; Pfister, F.; Stalla, G. K.; Ende, G.; Weber-Fahr, W.; Fuss, J.; Gass, P.: Effects of a high-caloric diet and physical exercise on brain metabolite levels: a combined proton MRS and histologic study. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 35 (4), pp. 554 - 564 (2015)

Riebold, M.; Kozany, C.; Freiburger, L.; Sattler, M.; Buchfelder, M.; Hausch, F.; Stalla, G. K.; Páez-Pereda, M.: A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease. NATURE MEDICINE 21 (3), pp. 276 - 280 (2015)

Labeur, M.; Wölfel, B.; Stalla, J.; Stalla, G. K.: TMEFF2 is an endogenous inhibitor of the CRH signal transduction pathway. JOURNAL OF MOLECULAR ENDOCRINOLOGY 54 (1), pp. 51 - 63 (2015)

Geraedts, V.; Dimopoulou, C.; Auer, M.; Schopohl, J.; Stalla, G. K.; Sievers, C.: Health Outcomes in Acromegaly: Depression and Anxiety are Promising Targets for Improving Reduced Quality of Life. Frontiers in endocrinology 5, 229 (2015)

Dimopoulou, C.; Geraedts, V.; Stalla, G. K.; Sievers, C.: Neuropsychiatric and cardiometabolic comorbidities in patients with previously diagnosed Cushing's disease: a longitudinal observational study. BMJ open 5 (3), e006134 (2015)

Fuss, J.; Hellweg, R.; Van Caenegem, E.; Briken, P.; Stalla, G. K.; T'Sjoen, G.; Auer, M. K.: Cross-sex hormone treatment in male-to-female transsexual persons reduces serum brain-derived neurotrophic factor (BDNF). EUROPEAN NEUROPSYCHOPHARMACOLOGY 25 (1), pp. 95 - 99 (2015)

Perez-Rivas, L. G.; Theodoropoulou, M.; Ferrao, F.; Nusser, C.; Kawaguchi, K.; Stratakis, C. A.; Faucz, F. R.; Wildemberg, L. E.; Assie, G.; Beschorner, R. et al.; Dimopoulou, C.; Buchfelder, M.; Popovic, V.; Berr, C. M.; Toth, M.; Ardisasmita, A. I.; Honegger, J.; Bertherat, J.; Gadelha, M. R.; Beuschlein, F.; Stalla, G.; Komada, M.; Korbonits, M.; Reincke, M.: The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease. The Journal of clinical endocrinology and metabolism 100 (7), pp. E997 - E1004 (2015)

Roemmler-Zehrer, J.; Geigenberger, V.; Stoermann, S.; Ising, M.; Pfister, H.; Sievers, C.; Stalla, G. K.; Schopohl, J.: Specific behaviour, mood and personality traits may contribute to obesity in patients with craniopharyngioma. CLINICAL ENDOCRINOLOGY 82 (1), pp. 106 - 114 (2015)

Stieg, M. R.; Sievers, C.; Farr, O.; Stalla, G. K.; Mantzoros, C. S.: Leptin: A hormone linking activation of neuroendocrine axes with neuropathology. PSYCHONEUROENDOCRINOLOGY 51, pp. 47 - 57 (2015)

Schoefl, C.; Honegger, J.; Droste, M.; Grussendorf, M.; Finke, R.; Ploeckinger, U.; Berg, C.; Willenberg, H. S.; Lammert, A.; Klingmueller, D. et al.; Jaursch-Hancke, C.; Toenjes, A.; Schneidewind, S.; Flitsch, J.; Bullmann, C.; Dimopoulou, C.; Stalla, G.; Mayr, B.; Hoeppner, W.; Schopohl, J.: Frequency of AIP Gene Mutations in Young Patients With Acromegaly: A Registry-Based Study. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 99 (12), pp. E2789 - E2793 (2014)

Dimopoulou, C.; Athanasoulia, A. P.; Hanisch, E.; Held, S.; Sprenger, T.; Toelle, T. R.; Roemmler-Zehrer, J.; Schopohl, J.; Stalla, G. K.; Sievers, C.: Clinical characteristics of pain in patients with pituitary adenomas. EUROPEAN JOURNAL OF ENDOCRINOLOGY 171 (5), pp. 581 - 591 (2014)

Auer, M. K.; Fuss, J.; Höhne, N.; Stalla, G. K.; Sievers, C.: Transgender Transitioning and Change of Self-Reported Sexual Orientation. PLOS ONE 9 (10), e110016 (2014)

Athanasoulia, A. P.; Stalla, G. K.; Auer, M. K.: Insights into the coexistence of two mutations in the same LHCGR gene locus causing severe Leydig cell hypoplasia. HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM 13 (3), pp. 424 - 429 (2014)

Occhi, G.; Regazzo, D.; Albiger, N. M.; Ceccato, F.; Ferasin, S.; Scanarini, M.; Denaro, L.; Cosma, C.; Plebani, M.; Cassarino, M. F. et al.; Mantovani, G.; Stalla, G. K.; Giraldi, F. P.; Paez-Pareda, M.; Scaroni, C.: Activation of the Dopamine Receptor Type-2 (DRD2) Promoter by 9-Cis Retinoic Acid in a Cellular Model of Cushing's Disease Mediates the Inhibition of Cell Proliferation and ACTH Secretion Without a Complete Corticotroph-to-Melanotroph Transdifferentiation. ENDOCRINOLOGY 155 (9), pp. 3538 - 3549 (2014)

Wu, Y.; Lucia, K.; Lange, M.; Kuhlen, D.; Stalla, G. K.; Renner, U.: Hypoxia inducible factor-1 is involved in growth factor, glucocorticoid and hypoxia mediated regulation of vascular endothelial growth factor-A in human meningiomas. JOURNAL OF NEURO-ONCOLOGY 119 (2), pp. 263 - 273 (2014)